Reaktion #2259569

ord-bb213d5b29d14d26bb66929debc2a276

Reaktionsgleichung

CCOC(=O)c1cnc(SC)nc1C(=O)c1cccc(Cl)n1
suspension
CCOC(=O)c1cnc(SC)nc1C(=O)c1cccc(Cl)n1
ethyl 4-(6-chloropicolinoyl)-2-(methylthio)pyrimidine-5-carboxylate
Cl.NNc1c(Cl)cccc1Cl
2,6-dichlorophenylhydrazine hydrochloride
CSc1ncc2c(=O)n(-c3c(Cl)cccc3Cl)nc(-c3cccc(Cl)n3)c2n1
title compound
CSc1ncc2c(=O)n(-c3c(Cl)cccc3Cl)nc(-c3cccc(Cl)n3)c2n1
8-(6-chloropyridin-2-yl)-6-(2,6-dichlorophenyl)-2-(methylthio)pyrimido[4,5-d]pyridazin-5(6H)-one

Reaktionsbedingungen

Temperatur
108°CELSIUS
Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigeThe mixture was partitioned between ethyl acetate and brine
  2. 2
    EinengenThe organic phase was concentrated
  3. 3
    Sonstigethe residue was purified by flash chromatography (15-50% ethyl acetate in hexane)

Vorschrift

To a suspension of Example 159A (512 mg, 1.516 mmol) in 2,2,2-trifluoroethanol (15 mL) was added 2,6-dichlorophenylhydrazine hydrochloride (324 mg, 1.516 mmol). This mixture was heated in a sealed tube at 108° C. overnight. The mixture was partitioned between ethyl acetate and brine. The organic phase was concentrated, and the residue was purified by flash chromatography (15-50% ethyl acetate in hexane) to provide the title compound. MS (DCI/NH3) m/z 451 (M+H)+.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US09051327B2uspto-grants-2015_06